As a subtype of IL-13, high IL13RA1 expression has been found to have a poor prognosis in patients with invasive BC and was associated with HER2- and a high Ki-67 index, showing its role of potential prognostic marker in BC [41]. This evidence concerns the gene IL13 and breast cancer.